Bio-Rad Laboratories | BIO - Operating Profit

Stock Price
288.08
Daily Change
-7.35 -2.49%
Monthly
8.90%
Yearly
-10.70%
Q3 Forecast
292.98

Bio-Rad Laboratories reported $77.1M in Operating Profit for its fiscal quarter ending in June of 2025.




Operating Profit Change Date
Abbott USD 2.07B 415M Jun/2025
Agilent USD 360M 60M Jul/2025
Becton, Dickinson and Co. USD 979M 433M Jun/2025
Bio Techne USD -23860000 62.57M Jun/2025
Bio-Rad Laboratories USD 77.1M 53.4M Jun/2025
Bruker USD 11.9M 19.9M Jun/2025
Charles River Laboratories USD 132.33M 57.66M Jun/2025
Danaher USD 760M 523M Jun/2025
Exact Sciences USD -2148000 93.86M Jun/2025
General Electric Aerospace USD 2.1B 356M Jun/2025
Hologic USD 260.9M 267.9M Jun/2025
Illumina USD 214M 83M Jun/2025
IQVIA Holdings USD 556M 64M Jun/2025
Laboratory Of America USD 462.8M 130.4M Jun/2025
Merck USD 6.36B 494M Jun/2025
Mettler Toledo International USD 265.71M 63.77M Jun/2025
Myriad Genetics USD -29000000 10M Mar/2025
Quest Diagnostics USD 438M 92M Jun/2025
Repligen USD 5.96M 621K Jun/2025
Revvity USD 90.76M 18.53M Jun/2025
Roche Holding CHF 4.39B 1.04B Dec/2024
Siemens EUR 2.76B 89M Jun/2025
Standard Biotools USD -23700000 9.12M Jun/2025
Thermo Fisher Scientific USD 1.92B 200M Jun/2025
Tosoh JPY 16.08B 10.8B Jun/2025
Waters USD 188.21M 36.47M Jun/2025